Safety and Efficacy of ThisCART22 in Patients With Refractory or Relapsed B Cell Malignancies
Clinical trial NCT04601181 · UNKNOWN
Trial details
- NCT number
- NCT04601181
- Sponsor
- Fundamenta Therapeutics, Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-23
- Primary completion
- 2022-10-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.